Ryan Kemper Quinn, PhD

Ryan Kemper Quinn, PhD has a diverse work experience. Ryan Kemper started their career as an Undergraduate Research Assistant at the College of the Holy Cross, where they focused on developing, synthesizing, and testing small molecule probes. Ryan Kemper then joined Amgen as part of the Amgen Scholars Program. Following that, they worked at the University of North Carolina at Chapel Hill as a Graduate Researcher, where they focused on developing new methods in organic synthesis. Recently, they joined Emerald Therapeutics as a Molecular Engineer, where they are involved in the development and scale-up of automation-based bioconjugation strategies for the synthesis of antiviral platform technologies and the management of custom small molecule synthesis projects.

Ryan Kemper Quinn, PhD completed their Bachelor's Degree in Chemistry at the College of the Holy Cross from 2007 to 2011. Following that, they pursued their Doctor of Philosophy (Ph.D.) in Organic Chemistry at the University of North Carolina at Chapel Hill, which they obtained from 2011 to 2016.